DOCSLIB.ORG

DIP-Trypsin,2 and DIP-Subtilisin (Novo).3 A-Chymotrypsin Was First Investigated

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DIP-Trypsin,2 and DIP-Subtilisin (Novo).3 A-Chymotrypsin Was First Investigated VOL. 51, 1964 BIOCHEMISTRY: T. VISWANATHA 1117 as it rises in b to enter c above the midline, etc. It can be easily seen that a similar oscillation about the midline takes place in the rotating fluid annulus of Figure 4a and in the more general situation of Figure 4b. These oscillations can be made quite small by adjusting the density of the buffer to match the particle density and by speeding up the rate of buffer flow to shorten the period of settling. The principle of eliminating thermal convection in continuous flow electrophoresis presented here can be implemented experimentally in a variety of ways. The various methods of approach will be published in this journal. Summary.-The process of generation of thermal convection is considered with an emphasis on two special cases: (1) a thin fluid sheath between two parallel vertical walls with a horizontal temperature gradient maintained in the fluid; (2) a thin fluid sheath between two parallel horizontal plates with a vertical temperature gradient maintained in the fluid to obtain a density decrease with depth. The patterns of thermal convection are described, and it is shown how both types of convection can be inhibited by allowing the fluid sheath to flow through a closed or a meandering channel in such a fashion that the relative orientation between the gravitational field and the convection pattern is periodically reversed. * This work has been aided by a grant from the Office of Naval Research. Lord Rayleigh, Phil. Mag., 32, 529-546 (1916). 2 Jacob, M., Heat Transfer (Wiley, 1949), vol. 1. Sanders, V., "Laminar free convection between smooth vertical parallel plates," thesis, University of California (Los Angeles), 1962. 4 B6nard, H., Ann. Chim. Phys., 23, 62-144 (1901). 'Liu, Chen-Ya, "Natural convection heat transfer in long horizontal cylindrical annuli," thesis, New York Univ., 1961. 6 Hjertkn, S., Arkiv Kemi, 13, 151 (1958). 7 Kolin, A., these PROCEEDINGS, 46, 509 (1960). 8 Kolin, A., J. Chem. Phys., 22, 1628 (1954). 9 Kolin, A., Biochim. et Biophys. Acta, 32, 538 (1959). 10 Kolin, A., J. Appl. Phys., 25, 1442 (1954). 1Kolin, A., and P. Cox, these PROCEEDINGS, in press. STUDIES ON THE ACTIVE SITE OF CHYMOTRYPSIN* BY T. VISWANATHA INSTITUTE OF MOLECULAR BIOLOGY, UNIVERSITY OF OREGON, EUGENE Communicated by V. Boekelheide, April 6, 1964 Studies were undertaken to investigate the nature of the amino acids, especially of the serine residue, associated with the phosphopeptides of DIP-chymotrypsin,l DIP-trypsin,2 and DIP-subtilisin (Novo).3 a-Chymotrypsin was first investigated. In a typical experiment, 2.5 gm of 3 X recrystallized a-chymotrypsin was converted to its DIP-derivative by treat- ment with DFP at pH 8.0. After the removal of excess DFP by extensive dialysis against 0.001 N HC1, the DIP-protein was subjected to enzymatic degradation at 370C in the following order: the pepsin at pH 2.10 (8 hr); chymotrypsin and tryp- sin at pH 8.0 (8 hr); carboxypeptidases A and B at pH 7.80 (8 hr); and finally with Downloaded by guest on September 28, 2021 1118 BIOCHEMISTRY: 7'. VJSWANATHA PROC. N. A. S. leucylaininopeptidase at pH 8.0 (8 hr) in the presence of 0.005 AI MgC12. The total amount of each enzyme used was 1-1.5 parts per 1000 parts of DIP-protein. The enzymatic digest of the DIP-protein was adjusted to pH 4.0 and taken to dryness with the aid of a Rinco flash evaporator. The residue so obtained was refluxed with 25 ml of redistilled HCl for 20 min. The hydrolysate was taken to dryness under vacuum. The purification and the properties of the phosphopep- tides are described in the flow sheet. FLOW SHEET SHOWING THE PURIFICATION OF PHOSPHOPEPTIDES Hydrolysis of the Enzyme Digest of DIP-Chymotrypqin Remarks Dowex 50 (H+) Chromatography 1. Acidiefraction plus water washings 1. This fraction contains phosphopeptides and small amounts of aspartic acid and glu- Rechromatography on 150-cm long column tamic acid. Recovery of bound phosphorus of the amino acid analyzer; elution with 0.2 50% based on phosphate determination. N Na citrate buffer, pH 3.25, temp 500C. It reduces alkaline triphenyl tetrazolium Procedure the same as Spackman et al.4 chloride (TPTZ). 2. Fraction appearing at 40-60 ml effluent volume 2. This fraction reduces alkaline TPTZ; it re- collected and desalted solves into 3 components as shown in Fig. la; amino acid composition AsP: Ser-P: Rechromatography of material corresponding Gly: Glu: 1:2.5:1:1; Total nitrogen to peaks I & II (Fig. la) on 150-cm long present in an aliquot of sample 90 ug; column; conditions same as above except nitrogen recovered in the form of amino temp 30°C. acids in the acid hydrolysate of an identical aliquot of the sample 42 pg; material in Peak III analyses for Ser, ornithine, and arginine (see text). 3. Acidic comrnpornents (Fi. lb) 3. Component A reduces alkaline TPTZ; A i amino acid composition Asp, (Ser-P)2 Gly, A B C X2 (see text for details). Rechromatography4 on 50-cm medium column, 0.38 N Na citrate buffer, pH 4.26 (Fig. lc) 4. Al A2 4. Al - (Asp, Ser-P, Gly, X). A2 - (Ser, X). See text. The desalting of all the phosphopeptide fractions (2, 3, and 4, flow sheet) prior to chromatography was achieved by acidification with 2 N HC1 followed by extraction with ether to remove the citric acid formed. The ether-extracted material was taken to dryness and was then treated with 10 ml of absolute ethanol. After the removal of the precipitated NaCl, the alcohol solution containing the phospho- peptides was taken to dryness. The observed discrepancy between the total nitrogen determined according to the procedure of Lanni et al.5 and the nitrogen recovered in the form of amino acids from the phosphopeptide fraction 2 (flow sheet) prompted an analysis of the materialin peak III in Figure la. This material was isolated and was analyzed for its amino acid composition. An analysis of the acid hydrolysate of this material showed the presence of serine; ornithine and arginine were found upon treatment of the hydrolysate with ammonia. Serine and the basic amino acids were present in equimolar amounts. Downloaded by guest on September 28, 2021 VOL. 51, 1964 BIOCHEMISTRY: T. VISWANATHA 1119 .8 _ - .-(a) a.4_._ .. I- 00 27 47 67 .87 107 127 147 167 187 207 227 247 267 ° .6_ r (b) .2 , . -. z 0 26 46 66 86 106 126 146 166 I.6 _ .Ai ¢.4(C ) A2 0*° .2 _- . 0 A 0 23 43 63 83 103 123 143 163 183 203 223 243 263 28 EFFLUENT VOLUME (m8 FIG. 1.-(a) A typical chromatogram of the phosphopeptide fraction (2, flow sheet) on a 50-cm medium column. 0.38 N Na citrate buffer, tempr 3000, pH 4.26. (b) Rechromatography of the acidic material in phosphopeptide fraction (2, flow sheet) on 150-cm long column, 0.2 N Na citrate buffer, temp 300C, pH 3.25. (c) Chromatogram of component A (b) on 50-cm medium column. (All analyses were made immediately after the isolation of the fractions mentioned.) Since the above results suggested the presence of an unusual arginine residue in the phosphopeptide, further chromatographic purification of the phosphopeptides was accomplished leading to the isolation of component A (3, flow sheet). Phosphate and amino acid analysis of 16-hr acid hydrolysate of Component A showed the presence of P, Asp, Ser, and Gly in the ratio 2:1:2: 1. An ammonia peak with an accompanying shoulder was observed. No basic amino acids were noticed. How- ever, treatment of component A with 2 N ammonium hydroxide resulted in the release of arginine in amounts equivalent to the serine present. The same amount of arginine was found in the acid hydrolysate of the ammonia-treated component A, suggesting that all of arginine present was released free from the rest of the com- ponent A upon ammonia treatment. Thus, the amino acid composition of com- ponent A appears to be [Asp, (Ser-P)2gly, X2], X6 being the source of arginine. Treatment of 16-hr acid hydrolysate of component A with 3 N ammonium hy- droxide and analysis showed the presence of ornithine in addition to the amino acids mentioned earlier. Hydrolysis of component A with HCl in the presence of HCl04 led to the formation of glutamic acid and pyrrolidone carboxylic acid, in addition to the amino acids observed in the absence of HCl04. These results are consistent with X being an unusual arginine residue. Aspartic acid and serine were found to occupy N-terminal position from analysis of component A treated with dinitrofluorobenzene, suggesting component A is a mixture of two phosphopeptides. Indeed, on rechromatography of component A on 50-cm medium column, it resolves into two substances, Al and A2 (Fig. lc). The substance A2 results presumably due to dephosphorylation of one of the phosphopeptides present in component A, during the desalting procedure employed. It has also been observed earlier (peak III, Fig. la), and its amino acid composition is (Ser, X). The phosphopeptide Downloaded by guest on September 28, 2021 1120 BIOCHEMISTRY: T. VISWANATHA PROC. N. A. S. (Ser, X, P) which is the source of A2, arises from the degradation of Al during the acid hydrolysis employed in the preparation of phosphopeptides. The appearance of arginine following ammonia treatment of 3 X chromatographed component A (only the acidic fraction being used in each rechromnatography), as well as the close stoichiometric relationship observed between arginine and the other amino acids present in component A, suggest the presence of "an activated guanido group" in the chymotrypsin.
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0346364 A1 BRUNS Et Al
    US 2016.0346364A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0346364 A1 BRUNS et al. (43) Pub. Date: Dec. 1, 2016 (54) MEDICAMENT AND METHOD FOR (52) U.S. Cl. TREATING INNATE IMMUNE RESPONSE CPC ........... A61K 38/488 (2013.01); A61K 38/482 DISEASES (2013.01); C12Y 304/23019 (2013.01); C12Y 304/21026 (2013.01); C12Y 304/23018 (71) Applicant: DSM IPASSETS B.V., Heerlen (NL) (2013.01); A61K 9/0053 (2013.01); C12N 9/62 (2013.01); A23L 29/06 (2016.08); A2ID 8/042 (72) Inventors: Maaike Johanna BRUINS, Kaiseraugst (2013.01); A23L 5/25 (2016.08); A23V (CH); Luppo EDENS, Kaiseraugst 2002/00 (2013.01) (CH); Lenneke NAN, Kaiseraugst (CH) (57) ABSTRACT (21) Appl. No.: 15/101,630 This invention relates to a medicament or a dietary Supple (22) PCT Filed: Dec. 11, 2014 ment comprising the Aspergillus niger aspergilloglutamic peptidase that is capable of hydrolyzing plant food allergens, (86). PCT No.: PCT/EP2014/077355 and more particularly, alpha-amylase/trypsin inhibitors, thereby treating diseases due to an innate immune response S 371 (c)(1), in humans, and/or allowing to delay the onset of said (2) Date: Jun. 3, 2016 diseases. The present invention relates to the discovery that (30) Foreign Application Priority Data the Aspergillus niger aspergilloglutamic peptidase is capable of hydrolyzing alpha-amylase/trypsin inhibitors that are Dec. 11, 2013 (EP) .................................. 13196580.8 present in wheat and related cereals said inhibitors being strong inducers of innate immune response. Furthermore, Publication Classification the present invention relates to a method for hydrolyzing alpha-amylase/trypsin inhibitors comprising incubating a (51) Int.
    [Show full text]
  • Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases
    International Journal of Molecular Sciences Review Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases Emma L. Carroll 1,†, Mariarca Bailo 2,†, James A. Reihill 1 , Anne Crilly 2 , John C. Lockhart 2, Gary J. Litherland 2, Fionnuala T. Lundy 3 , Lorcan P. McGarvey 3, Mark A. Hollywood 4 and S. Lorraine Martin 1,* 1 School of Pharmacy, Queen’s University, Belfast BT9 7BL, UK; [email protected] (E.L.C.); [email protected] (J.A.R.) 2 Institute for Biomedical and Environmental Health Research, School of Health and Life Sciences, University of the West of Scotland, Paisley PA1 2BE, UK; [email protected] (M.B.); [email protected] (A.C.); [email protected] (J.C.L.); [email protected] (G.J.L.) 3 Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast BT9 7BL, UK; [email protected] (F.T.L.); [email protected] (L.P.M.) 4 Smooth Muscle Research Centre, Dundalk Institute of Technology, A91 HRK2 Dundalk, Ireland; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Trypsin-like proteases (TLPs) belong to a family of serine enzymes with primary substrate specificities for the basic residues, lysine and arginine, in the P1 position. Whilst initially perceived as soluble enzymes that are extracellularly secreted, a number of novel TLPs that are anchored in the cell membrane have since been discovered. Muco-obstructive lung diseases (MucOLDs) are Citation: Carroll, E.L.; Bailo, M.; characterised by the accumulation of hyper-concentrated mucus in the small airways, leading to Reihill, J.A.; Crilly, A.; Lockhart, J.C.; Litherland, G.J.; Lundy, F.T.; persistent inflammation, infection and dysregulated protease activity.
    [Show full text]
  • Mixture of Trypsin, Chymotrypsin and Papain Reduces Formation of Metastases and Extends Survival Time of C57bl6 Mice with Syngeneic Melanoma B16
    Cancer Chemother Pharmacol #2001) 47 #Suppl): S16±S22 Ó Springer-Verlag 2001 ORIGINAL ARTICLE Martin Wald á Toma sÏ Oleja r á Veronika SÏ ebkova Marie Zadinova á Michal Boubelõ k á Pavla PoucÏ kova Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16 Abstract Purpose: The aim of the present study was to decreased expression of CD44 and CD54 molecules in investigate the eect of a mixture of proteolytic enzymes tumors exposed to proteolytic enzymes in vivo. #comprising trypsin, chymotrypsin and papain) on the Conclusions: Our data suggest that serine and cysteine metastatic model of syngeneic melanoma B16. Methods: proteinases suppress B16 melanoma, and restrict its 140 C57Bl6 mice were divided into two control and two metastatic dissemination in C57Bl6 mice. ``treated'' groups. Control groups received saline rectally, twice a day starting 24 h after intracutaneous Key words Trypsin á Papain á B16 melanoma á transplantation #C1) or from the time point of the Metastasis primary B16 melanoma extirpation #C2), respectively. ``Treated'' groups were rectally administered a mixture of 0.2 mg trypsin, 0.5 mg papain, and 0.2 mg chymo- Introduction trypsin twice daily starting 24 h after transplantation #E1) or after extirpation of the tumor #E2), respectively. Lack of requisite immune surveillance in tissue dier- Survival of mice and B16 melanoma generalization were entiation is an important mechanism that gives rise to a observed for a period of 100 days. Immunological clone of malignant cells, which eventuates in tumori- evaluation of B16 melanoma cells in the ascites was genesis.
    [Show full text]
  • TMPRSS2 and Furin Are Both Essential for Proteolytic Activation and Spread of SARS-Cov-2 in Human Airway Epithelial Cells and Pr
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.15.042085; this version posted April 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS- 2 CoV-2 in human airway epithelial cells and provide promising drug targets 3 4 5 Dorothea Bestle1#, Miriam Ruth Heindl1#, Hannah Limburg1#, Thuy Van Lam van2, Oliver 6 Pilgram2, Hong Moulton3, David A. Stein3, Kornelia Hardes2,4, Markus Eickmann1,5, Olga 7 Dolnik1,5, Cornelius Rohde1,5, Stephan Becker1,5, Hans-Dieter Klenk1, Wolfgang Garten1, 8 Torsten Steinmetzer2, and Eva Böttcher-Friebertshäuser1* 9 10 1) Institute of Virology, Philipps-University, Marburg, Germany 11 2) Institute of Pharmaceutical Chemistry, Philipps-University, Marburg, Germany 12 3) Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon 13 State University, Corvallis, USA 14 4) Fraunhofer Institute for Molecular Biology and Applied Ecology, Gießen, Germany 15 5) German Center for Infection Research (DZIF), Marburg-Gießen-Langen Site, Emerging 16 Infections Unit, Philipps-University, Marburg, Germany 17 18 #These authors contributed equally to this work. 19 20 *Corresponding author: Eva Böttcher-Friebertshäuser 21 Institute of Virology, Philipps-University Marburg 22 Hans-Meerwein-Straße 2, 35043 Marburg, Germany 23 Tel: 0049-6421-2866019 24 E-mail: [email protected] 25 26 Short title: TMPRSS2 and furin activate SARS-CoV-2 spike protein 27 28 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.15.042085; this version posted April 15, 2020.
    [Show full text]
  • Intrinsic Evolutionary Constraints on Protease Structure, Enzyme
    Intrinsic evolutionary constraints on protease PNAS PLUS structure, enzyme acylation, and the identity of the catalytic triad Andrew R. Buller and Craig A. Townsend1 Departments of Biophysics and Chemistry, The Johns Hopkins University, Baltimore MD 21218 Edited by David Baker, University of Washington, Seattle, WA, and approved January 11, 2013 (received for review December 6, 2012) The study of proteolysis lies at the heart of our understanding of enzyme evolution remain unanswered. Because evolution oper- biocatalysis, enzyme evolution, and drug development. To un- ates through random forces, rationalizing why a particular out- derstand the degree of natural variation in protease active sites, come occurs is a difficult challenge. For example, the hydroxyl we systematically evaluated simple active site features from all nucleophile of a Ser protease was swapped for the thiol of Cys at serine, cysteine and threonine proteases of independent lineage. least twice in evolutionary history (9). However, there is not This convergent evolutionary analysis revealed several interre- a single example of Thr naturally substituting for Ser in the lated and previously unrecognized relationships. The reactive protease catalytic triad, despite its greater chemical similarity rotamer of the nucleophile determines which neighboring amide (9). Instead, the Thr proteases generate their N-terminal nu- can be used in the local oxyanion hole. Each rotamer–oxyanion cleophile through a posttranslational modification: cis-autopro- hole combination limits the location of the moiety facilitating pro- teolysis (10, 11). These facts constitute clear evidence that there ton transfer and, combined together, fixes the stereochemistry of is a strong selective pressure against Thr in the catalytic triad that catalysis.
    [Show full text]
  • Faecal Elastase 1: Not Helpful in Diagnosing Chronic Pancreatitis Associated with Mild to Gut: First Published As 10.1136/Gut.42.4.551 on 1 April 1998
    Gut 1998;42:551–554 551 Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to Gut: first published as 10.1136/gut.42.4.551 on 1 April 1998. Downloaded from moderate exocrine pancreatic insuYciency P G Lankisch, I Schmidt, H König, D Lehnick, R Knollmann, M Löhr, S Liebe Abstract tion. The former is particularly helpful Background/Aim—The suggestion that only in detecting severe EPI, but not the estimation of faecal elastase 1 is a valuable mild to moderate form, which poses the new tubeless pancreatic function test was more frequent and diYcult clinical prob- evaluated by comparing it with faecal chy- lem and does not correlate significantly motrypsin estimation in patients catego- with the severe morphological changes rised according to grades of exocrine seen in chronic pancreatitis. pancreatic insuYciency (EPI) based on (Gut 1998;42:551–554) the gold standard tests, the secretin- pancreozymin test (SPT) and faecal fat Keywords: faecal elastase 1; faecal chymotrypsin; analysis. secretin-pancreozymin test; faecal fat analysis; exocrine pancreatic insuYciency; diagnosis Methods—In 64 patients in whom EPI was suspected, the following tests were per- formed: SPT, faecal fat analysis, faecal The diagnosis of chronic pancreatitis is usually chymotrypsin estimation, faecal elastase 1 based on abnormal results from pancreatic estimation. EPI was graded according to function tests and morphological examin- the results of the SPT and faecal fat ation.1 For the evaluation of exocrine pancre- analysis as absent, mild, moderate, or atic function, there are both direct and indirect severe. The upper limit of normal for fae- tests.
    [Show full text]
  • Role of Chicken Pancreatic Trypsin, Chymotrypsin and Elastase in the Excystation Process of Eimeria Tenella Oocysts and Sporocysts
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Obihiro University of Agriculture and Veterinary Medicine Academic Repository Role of Chicken Pancreatic Trypsin, Chymotrypsin and Elastase in the Excystation Process of Eimeria tenella Oocysts and Sporocysts 著者（英） Guyonnet Vincent, Johnson Joyce K., Long Peter L. journal or The journal of protozoology research publication title volume 1 page range 22-26 year 1991-10 URL http://id.nii.ac.jp/1588/00001722/ J. Protozool. Res., 1. 22-26(1991) Copyright © 1991 , Research Center for Protozoan Molecular Immunology Role of Chicken Pancreatic Trypsin, Chymotrypsin and Elastase in the Excystation Process of Eimeria tenella Oocysts and Sporocysts VINCENT GUYONNET, JOYCE K. JOHNSON, and PETER L. LONG Department of Poultry Science, The University of Georgia Athens, GA 30602, U.S.A. Recieved 2 September 1991 / Accepted October 5 1991 Key words: chymotrypsin, Eimeria tenella, elastase, excystation, trypsin ABSTRACT The role of pancreatic proteolytic enzymes in the excystation process of Eimeria tenella oocysts and sporocysts was studied in vitro. Intact sporulated oocysts were preincubated in phosphate buffer, NaCl 0.9% (PBS) added with 0.5% chicken bile extract in a 5% C02 atmosphere for 30 minutes prior to exposure to either 0.25% (w/v) chicken trypsin, chymotrypsin, pancreatic elastase, or a 1% (w/v) crude extract of unsporulated and sporulated oocysts of E. tenella (Expt.1). No excystation was observed under these conditions. Sporocysts were also incubated under the same conditions without pretreatment in C02. Excystation was observed for sporocysts incubated with either trypsin, chymotrypsin or pancreatic elastase, the best percentage of excystation being recorded for the latter after 5 hours (Expt.
    [Show full text]
  • 372 Trypsin-Chymotrypsin Alternation and Other
    372 TRYPSIN-CHYMOTRYPSIN ALTERNATION AND OTHER DIGESTIVE ENZYMES DURING THE DAILY DIGESTION IN EARLY SENEGAL SOLE JUVENILES N. Gilannejad 1, C. Navarro-Guillén 1, G. Martínez-Rodríguez 1, F.J. Moyano 2, M. Yúfera 1 1 Instituto de Ciencias Marinas de Andalucía (ICMAN-CSIC), 11519 Puerto Real, Cádiz, Spain. 2 Dept. Biology and Geology, University of Almería, 04120-Almería, Spain * E-mail: [email protected] Introduction The improvement of diets and the utilization of their nutrients by growing fish is a major challenge in fish farming. In vitro experiments with customized bioreactors simulating the digestion conditions are considered as an easy-working and quick methodology for improving feed formulation. Nevertheless, it is first necessary to define realistic digestion conditions according to the target species. In a first step to advance in the integral knowledge of the digestive function in Senegal sole (Solea senegalensis), we have analysed the activity pattern of some key digestive enzymes during a 24 hours period in early juveniles with different daily feeding frequencies. Materials and methods Juvenile Senegal sole with an average weight of 10±0.3 g were reared in four 400-L tanks with flow-through water system with a temperature of 19.5 ± 1.0 ° C and a natural light/dark photoperiod. Fish were fed daily on an experimental diet with a ratio of 2% fish wet weight with four different feeding protocol: a) one daily meal at 9:00 h (local time), b) six daily meals during daylight at 08:30, 10:00, 12:00, 14:00, 16:00, and 18:00 h, c) six daily meals during night at 20:00, 22:00, 24:00, 02:00, 04:00 and 06:00 and, d) 12 daily meals during 24 hour (at times mentioned in protocols b and c).
    [Show full text]
  • The Nature and Applications of Tryptic Enzymes in Veterinary Practice
    Volume 20 | Issue 1 Article 1 1958 The aN ture and Applications of Tryptic Enzymes in Veterinary Practice Earl F. Huffman Follow this and additional works at: https://lib.dr.iastate.edu/iowastate_veterinarian Part of the Veterinary Toxicology and Pharmacology Commons Recommended Citation Huffman, Earl F. (1958) "The aN ture and Applications of Tryptic Enzymes in Veterinary Practice," Iowa State University Veterinarian: Vol. 20 : Iss. 1 , Article 1. Available at: https://lib.dr.iastate.edu/iowastate_veterinarian/vol20/iss1/1 This Article is brought to you for free and open access by the Journals at Iowa State University Digital Repository. It has been accepted for inclusion in Iowa State University Veterinarian by an authorized editor of Iowa State University Digital Repository. For more information, please contact [email protected]. The Nature And Applications Of TRYPTIC ENZYMES IN VETERINARY PRACTICE Earl F. Huffman, D.V.M. NZYMES, or ferments as they were glands of domestic animals (trypsin), or E known in earlier times, have been from the vegetable kingdom as in the case used in medicine for centuries. From the of papain. time of Pasteur interest in enzymes has Of the three major types papain is per­ increased till, at the present date, we have haps the most proteolytic of the group (1). active research groups devoting much However, it strongly attacks viable mam­ time and money to the study of the nature malian proteins and is difficult to control and applied uses of a great variety of unless very closely supervised in its ap­ enzymes. plication. For that reason papain has be­ .
    [Show full text]
  • BMC Structural Biology Biomed Central
    BMC Structural Biology BioMed Central Research article Open Access A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases Alexander Wlodawer*1, Stewart R Durell2, Mi Li1,3, Hiroshi Oyama4, Kohei Oda4 and Ben M Dunn5 Address: 1Protein Structure Section, Macromolecular Crystallography Laboratory, National Cancer Institute at Frederick, Frederick, MD 21702, USA, 2Laboratory of Experimental and Computational Biology, National Cancer Institute, Bethesda, MD 20892, USA, 3Basic Research Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702, USA, 4Department of Applied Biology, Faculty of Textile Science, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan and 5Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32610, USA Email: Alexander Wlodawer* - [email protected]; Stewart R Durell - [email protected]; Mi Li - [email protected]; Hiroshi Oyama - [email protected]; Kohei Oda - [email protected]; Ben M Dunn - [email protected] * Corresponding author Published: 11 November 2003 Received: 23 July 2003 Accepted: 11 November 2003 BMC Structural Biology 2003, 3:8 This article is available from: http://www.biomedcentral.com/1472-6807/3/8 © 2003 Wlodawer et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. Abstract Background: Tripeptidyl-peptidase I, also known as CLN2, is a member of the family of sedolisins (serine-carboxyl peptidases). In humans, defects in expression of this enzyme lead to a fatal neurodegenerative disease, classical late-infantile neuronal ceroid lipofuscinosis.
    [Show full text]
  • Recombinant Bovine Enteropeptidase/Enterokinase
    Recombinant Bovine Enteropeptidase/Enterokinase Catalog Number: 4139-SE DESCRIPTION Source E. coli­derived Cys788­Lys800 (heavy chain C­terminal fragment) with an N­terminal Ala, & Ile801­His1035 (light chain) Accession # P98072 N­terminal Sequence Ala & Ile801 Analysis Structure / Form Disulfide­linked heterodimer Predicted Molecular 1.5 kDa (heavy chain C­terminal fragment), 26 kDa (light chain) Mass SPECIFICATIONS SDS­PAGE 34 kDa, reducing conditions 30 kDa, non­reducing conditions Activity Measured by its ability to cleave a colorimetric peptide substrate, N­carbobenzyloxy­Lys­ThioBenzyl ester (Z­Lys­SBzl), in the presence of 5,5’Dithio­bis (2­nitrobenzoic acid) (DTNB). Lu, D. et al. (1997) J. Biol. Chem. 272:31293. The specific activity is >35 nmol/min/µg, as measured under the described conditions. Endotoxin Level <1.0 EU per 1 μg of the protein by the LAL method. Purity >90%, by SDS­PAGE under reducing conditions and visualized by silver stain. Formulation Supplied as a 0.2 μm filtered solution in Glycerol, NaCl and HEPES. See Certificate of Analysis for details. Activity Assay Protocol Materials l Assay Buffer: 50 mM Tris, pH 7.5 l Recombinant Bovine Enteropeptidase/Enterokinase (rbEnterokinase) (Catalog # 4139­SE) l Substrate: Z­Lys­SBZL (Bachem, Catalog # M­1300), 10 mM stock in DMSO l 5,5’­dithio­bis (2­nitrobenzoic acid) (DTNB) (Sigma, Catalog # D­8130), 10 mM stock in DMSO l 96 well Clear Plate (Costar, Catalog # 92592) l Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent Assay 1. Dilute rbEnterokinase to 0.04 µg/mL in Assay Buffer. 2. Dilute Substrate to 200 µM in Assay Buffer with 200 µM of DTNB.
    [Show full text]
  • Identification of Probiotic Effector Molecules: Present State and Future
    Available online at www.sciencedirect.com ScienceDirect Identification of probiotic effector molecules: present state and future perspectives 1 2 3 Sarah Lebeer , Peter A Bron , Maria L Marco , Jan-Peter Van 4 5 5 6,7 Pijkeren , Mary O’Connell Motherway , Colin Hill , Bruno Pot , 8 9 Stefan Roos and Todd Klaenhammer Comprehension of underlying mechanisms of probiotic action Introduction will support rationale selection of probiotic strains and targeted Recently, the International Scientific Association on Pro- clinical study design with a higher likelihood of success. This biotics and Prebiotics (ISAPP) reinforced the FAO/WHO will consequently contribute to better substantiation of health definition of probiotics, with minor changes: ‘live micro- claims. Here, we aim to provide a perspective from a microbiology organisms that, when administered in adequate amounts, point of view that such comprehensive understanding is not confer a health benefit on the host’ [1]. Documentation of straightforward. We show examples of well-documented health benefits is essential, but not a trivial task, because probiotic effector molecules in Lactobacillus and Bifidobacterium the monitoring of targeted health benefits of the applied strains, including surface-located molecules such as specific pili, probiotics is difficult to establish. Moreover, a plethora of S-layer proteins, exopolysaccharides, muropeptides, as well as modes of action has been postulated behind these health more widely produced metabolites such as tryptophan-related benefits from a host perspective (Box 1). Furthermore, and histamine-related metabolites, CpG-rich DNA, and various because of the limited knowledge of the underlying enzymes such as lactase and bile salt hydrolases. We also mechanisms by which probiotics elicit their effects, repro- present recent advances in genetic tool development, ducibility and rational strain selection is challenging.
    [Show full text]